CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...